CA2255121A1 - Compositions d'erythrocytes et procedes permettant de prelever et de stocker les erythrocytes - Google Patents

Compositions d'erythrocytes et procedes permettant de prelever et de stocker les erythrocytes Download PDF

Info

Publication number
CA2255121A1
CA2255121A1 CA002255121A CA2255121A CA2255121A1 CA 2255121 A1 CA2255121 A1 CA 2255121A1 CA 002255121 A CA002255121 A CA 002255121A CA 2255121 A CA2255121 A CA 2255121A CA 2255121 A1 CA2255121 A1 CA 2255121A1
Authority
CA
Canada
Prior art keywords
red
anticoagulant
approximately
blood
dextrose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002255121A
Other languages
English (en)
Inventor
Maria D. Gudino
Jose C. Deniega
Donald H. Buchholz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2255121A1 publication Critical patent/CA2255121A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Environmental Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La présente invention concerne des procédés permettant de prélever des érythrocytes, procédés selon lesquels on associe le sang total à un anticoagulant, on sépare les érythrocytes du sang total et on associe les érythrocytes séparés à une solution de stockage. Les érythrocytes peuvent être stockés pendant une longue période de temps.
CA002255121A 1997-03-17 1998-02-25 Compositions d'erythrocytes et procedes permettant de prelever et de stocker les erythrocytes Abandoned CA2255121A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81910697A 1997-03-17 1997-03-17
US08/819,106 1997-03-18
PCT/US1998/003712 WO1998041087A1 (fr) 1997-03-17 1998-02-25 Compositions d'erythrocytes et procedes permettant de prelever et de stocker les erythrocytes

Publications (1)

Publication Number Publication Date
CA2255121A1 true CA2255121A1 (fr) 1998-09-24

Family

ID=25227212

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002255121A Abandoned CA2255121A1 (fr) 1997-03-17 1998-02-25 Compositions d'erythrocytes et procedes permettant de prelever et de stocker les erythrocytes

Country Status (4)

Country Link
EP (1) EP0909128A1 (fr)
JP (1) JP4340927B2 (fr)
CA (1) CA2255121A1 (fr)
WO (1) WO1998041087A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003225174A1 (en) 2002-04-24 2003-11-10 Gambro, Inc. Removal of adenine during a process of pathogen reducing blood and blood components
US8052667B2 (en) 2004-09-07 2011-11-08 Velico Medical, Inc. Apparatus for prolonging survival of platelets
ATE495667T1 (de) 2004-10-15 2011-02-15 Velico Medical Inc Zusammensetzungen und verfahren für die verlängerung der überlebensdauer von blutplättchen
CA2826969C (fr) 2010-11-29 2019-02-19 New York Blood Center, Inc. Procede de rassemblement et de stockage de sang
JP6412696B2 (ja) * 2014-02-10 2018-10-24 テルモ株式会社 血清調製方法および器具
WO2020163774A1 (fr) * 2019-02-07 2020-08-13 The General Hospital Corporation Compositions, méthodes et nécessaires pour stabiliser des cellules et des échantillons biologiques

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5248506A (en) * 1986-03-19 1993-09-28 American National Red Cross Synthetic, plasma-free, transfusible storage medium for red blood cells and platelets

Also Published As

Publication number Publication date
JP4340927B2 (ja) 2009-10-07
JP2002522007A (ja) 2002-07-16
WO1998041087A1 (fr) 1998-09-24
EP0909128A1 (fr) 1999-04-21

Similar Documents

Publication Publication Date Title
US6527957B1 (en) Methods for separating, collecting and storing red blood cells
US5899874A (en) Preparation and method for production of platelet concentrates with significantly prolonged viabilty during storage
US9943077B2 (en) Methods for storing red blood cell products
US4111199A (en) Method of collecting transfusable granulocytes by gravity leukopheresis
JP4712135B2 (ja) 濃縮赤血球の調製における抗凝固及び保存用溶液
AU2004311906A1 (en) Processing systems and methods for providing leukocyte-reduced blood components conditioned for pathogen inactivation
EP0447399A1 (fr) Procede et recipient servant a la preparation et au stockage de concentres de plaquettes
WO1996029864A1 (fr) Methode de rajeunissement de globules rouges perimes
Gilcher et al. Apheresis: principles and technology of hemapheresis
JP4340927B2 (ja) 赤血球組成物、および赤血球を収集しそして保存するための方法
Heath et al. Treatment of antidepressant poisoning with resin hemoperfusion
US20220125043A1 (en) Methods and systems for processing biological fluids
Valbonesi et al. Erythrothrombocytapheresis and plasmathrombocytapheresis with storage in T-sol of platelets collected by the new Amicus cell separator
Yamamoto et al. A comparative study of the effect of autologous platelet-rich plasma and fresh autologous whole blood on haemostasis after cardiac surgery
Hallett Jr Minimizing the use of homologous blood products during repair of abdominal aortic aneurysms
Högman et al. A simple method for the preparation of microaggregate‐poor whole blood
EP2777727B1 (fr) Procédés et systèmes de traitement de fluides biologiques
Brickley et al. A comparison of two methods of post-bypass hemoconcentration
Valbonesi et al. Intraoperative blood salvage: a new trend in blood transfusion medicine
Heaton The quality of red blood cells
Anderson et al. Bone marrow processing on the Haemonetics V50 cell separator
Muylle et al. Separation of buffy coat using the top and bottom drainage system: reduction of red blood cell loss
Bruni et al. New options for multicomponent collection (MCC) with the latest cell separators
Walpoth et al. Blood salvage in cardiac surgery: Comparative analysis of three different procedures
Gombotz et al. Intraoperative Autotransfusion of RBC and PRP

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead